Omar Galdame Selected Research

Omar Galdame Research Topics

5	Infections 12/2018 - 09/2006
4	Fibrosis (Cirrhosis) 10/2017 - 09/2006
3	Persistent Infection 10/2017 - 01/2011
2	Chronic Hepatitis B 05/2014 - 12/2009
2	Hepatitis C 10/2011 - 01/2010
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Disease Progression 01/2015
1	Hepatocellular Carcinoma (Hepatoma) 03/2014
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2014
1	Hepatitis 01/2013
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2011
1	Essential Thrombocythemia 09/2010
1	Intestinal Diseases (Diseases, Intestinal) 12/2008
1	Chronic Hepatitis C 09/2006
1	Virus Diseases (Viral Diseases) 09/2006

2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2011
2	Interleukin-10 (Interleukin 10)IBA 10/2017 - 09/2006
2	Hepatitis B e AntigensIBA 01/2015 - 12/2009
1	Antiviral Agents (Antivirals)IBA 12/2018
1	HLA-DQ Antigens (HLA-DQ)IBA 10/2017
1	HLA-DP Antigens (HLA-DP)IBA 10/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2015
1	entecavir FDA Link 05/2014
1	CaspasesIBA 01/2013
1	Ribavirin (Virazole)FDA LinkGeneric 10/2011
1	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2011
1	Hyaluronic Acid (Hyaluronan)IBA 01/2011
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2011
1	Prothrombin (Factor II)IBA 09/2010
1	Immunoglobulin G (IgG)IBA 01/2010
1	RNA (Ribonucleic Acid)IBA 01/2010
1	AntibodiesIBA 01/2010
1	peginterferon alfa-2a (Pegasys)FDA Link 12/2009

2	Liver Transplantation 03/2014 - 01/2014
1	Blood Transfusion (Blood Transfusions) 01/2010
1	Therapeutics 12/2009
1	Transplantation 12/2008